| 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ... Polish Heart Journal (Kardiologia Polska) 73 (12), 1207-1294, 2015 | 12520* | 2015 |
| Subclinical hyperthyroidism and the risk of coronary heart disease and mortality TH Collet, J Gussekloo, DC Bauer, WPJ den Elzen, AR Cappola, ... Archives of internal medicine 172 (10), 799-809, 2012 | 627 | 2012 |
| Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts B Gencer, TH Collet, V Virgini, DC Bauer, J Gussekloo, AR Cappola, ... Circulation 126 (9), 1040-1049, 2012 | 593 | 2012 |
| Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol R Laaksonen, K Ekroos, M Sysi-Aho, M Hilvo, T Vihervaara, D Kauhanen, ... European heart journal 37 (25), 1967-1976, 2016 | 514 | 2016 |
| Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors XS Li, S Obeid, R Klingenberg, B Gencer, F Mach, L Räber, S Windecker, ... European heart journal 38 (11), 814-824, 2017 | 456 | 2017 |
| Adverse effects of statin therapy: perception vs. the evidence–focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract F Mach, KK Ray, O Wiklund, A Corsini, AL Catapano, E Bruckert, ... European heart journal 39 (27), 2526-2539, 2018 | 391 | 2018 |
| Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials B Gencer, NA Marston, KA Im, CP Cannon, P Sever, A Keech, ... The Lancet 396 (10263), 1637-1643, 2020 | 221 | 2020 |
| Ruling out coronary artery disease in primary care: development and validation of a simple prediction rule S Bösner, J Haasenritter, A Becker, K Karatolios, P Vaucher, B Gencer, ... Cmaj 182 (12), 1295-1300, 2010 | 221 | 2010 |
| Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes D Nanchen, B Gencer, R Auer, L Räber, GG Stefanini, R Klingenberg, ... European heart journal 36 (36), 2438-2445, 2015 | 191 | 2015 |
| Evolocumab for early reduction of LDL cholesterol levels in patients with acute coronary syndromes (EVOPACS) KC Koskinas, S Windecker, G Pedrazzini, C Mueller, S Cook, CM Matter, ... Journal of the American College of Cardiology 74 (20), 2452-2462, 2019 | 185 | 2019 |
| Lipoprotein (a): the revenant B Gencer, F Kronenberg, ES Stroes, F Mach European heart journal 38 (20), 1553-1560, 2017 | 183 | 2017 |
| Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update C Floriani, B Gencer, TH Collet, N Rodondi European heart journal 39 (7), 503-507, 2018 | 163 | 2018 |
| European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance … U Landmesser, M John Chapman, M Farnier, B Gencer, S Gielen, ... European heart journal 38 (29), 2245-2255, 2017 | 161* | 2017 |
| Prognostic value of PCSK9 levels in patients with acute coronary syndromes B Gencer, F Montecucco, D Nanchen, F Carbone, R Klingenberg, ... European Heart Journal 37 (6), 546-553, 2016 | 154 | 2016 |
| Small interfering RNA to reduce lipoprotein (a) in cardiovascular disease ML O’Donoghue, RS Rosenson, B Gencer, JAG López, NE Lepor, ... New England Journal of Medicine 387 (20), 1855-1864, 2022 | 153 | 2022 |
| Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by … AP Carnicelli, H Hong, SJ Connolly, J Eikelboom, RP Giugliano, ... Circulation 145 (4), 242-255, 2022 | 151 | 2022 |
| Prognosis of patients with familial hypercholesterolemia after acute coronary syndromes D Nanchen, B Gencer, O Muller, R Auer, S Aghlmandi, D Heg, ... Circulation 134 (10), 698-709, 2016 | 133 | 2016 |
| Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies B Gencer, TH Collet, V Virgini, R Auer, N Rodondi Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2013 | 106 | 2013 |
| Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST: Grupo de Trabajo de la Sociedad Europea de … M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ... Revista española de cardiología 68 (12), 1125. e1-1125. e64, 2015 | 98 | 2015 |
| Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score R Klingenberg, S Aghlmandi, L Räber, B Gencer, D Nanchen, D Heg, ... European Heart Journal: Acute Cardiovascular Care 7 (2), 129-138, 2018 | 96 | 2018 |
